May 1, 2017 — ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The award was presented to ClearFlow for its development of the PleuraFlow Active Clearance Technology (ACT) System, which has been clinically shown to reduce the occurrence of complications after cardiac surgery, according to the company.
Evidence suggests that chest tubes used for drainage after cardiac surgery have a high failure rate due to clogging. If the extra blood is not removed from inside the chest cavity after surgery, patients may require additional procedures, which are known as retained blood syndrome (RBS). Multiple studies have shown that retained blood has a statistically significant negative impact on cardiac surgery patients after surgery, including a higher likelihood of mortality, longer ICU and hospital lengths of stay, four times higher infection rates and increased cost of care.
ClearFlow’s PleuraFlow ACT System is the only U.S. Food and Drug Administration (FDA)-cleared device available, according to ClearFlow, that enables caregivers to proactively prevent or minimize chest tube occlusions and reduce retained blood.
Announcing ClearFlow as the recipient of the award in the ‘New Product Innovation’ category, Frost & Sullivan referred to PleuraFlow as a “transformational force in post-operative cardiothoracic surgery protocols.”
“Clearly, the PleuraFlow ACT System is uniquely positioned for sustained success as it meets customers’ core requirements of quality, functionality and reliability,” remarked Frost & Sullivan Senior Industry Analyst Patrick Riley.
Each year, Frost & Sullivan presents this award to the company that develops an innovative product to leverage leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it offers customers.
The PleuraFlow Active Clearance Technology System is approved for use in the United States, Europe, Australia, Brazil, Canada, and other countries in Asia and the Middle East.
For more information: www.clearflow.com
April 23, 2024 
